FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Lucy Schmidt

Research Profile

Disorders

Chemicals & Drugs

Anatomy

Physiology

Living Beings

Mouse

Devices

Oligonucleotide Array Sequence Analysis

Co-author Network

Publications

TOP 3
Lucy J Schmidt; Donald J Tindall
Androgen receptor: past, present and future.
Lucy J Schmidt; Thomas J Sebo; Donald J Tindall; Alissa R Verone; Gregory Wilding; Neelu Yadav; Christine M Lohse; James L Mohler; Elena A Pop; Kevin M Regan; Kristopher Attwood; Kelly Duncan; Hannelore V Heemers
RhoA as a mediator of clinically relevant androgen action in prostate cancer cells.
Lucy J Schmidt; Donald J Tindall
Steroid 5 α-reductase inhibitors targeting BPH and prostate cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Lucy Schmidt (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Lucy J Schmidt; Donald J Tindall
Androgen receptor: past, present and future.
Current drug targets 2013;14(4):401-7.
2012: Lucy J Schmidt; Thomas J Sebo; Donald J Tindall; Alissa R Verone; Gregory Wilding; Neelu Yadav; Christine M Lohse; James L Mohler; Elena A Pop; Kevin M Regan; Kristopher Attwood; Kelly Duncan; Hannelore V Heemers
RhoA as a mediator of clinically relevant androgen action in prostate cancer cells.
Molecular endocrinology (Baltimore, Md.) 2012;26(5):716-35.
2011: Lucy J Schmidt; Donald J Tindall
Steroid 5 α-reductase inhibitors targeting BPH and prostate cancer.
The Journal of steroid biochemistry and molecular biology 2011;125(1-2):32-8.
2010: Hannelore V Heemers; Lucy J Schmidt; Emily Kidd; Kristin A Raclaw; Kevin M Regan; Donald J Tindall
Differential regulation of steroid nuclear receptor coregulator expression between normal and neoplastic prostate epithelial cells.
The Prostate 2010;70(9):959-70.
2009: Diping Wang; R Bruce Montgomery; Lucy J Schmidt; Elahe A Mostaghel; Haojie Huang; Peter S Nelson; Donald J Tindall
Reduced tumor necrosis factor receptor-associated death domain expression is associated with prostate cancer progression.
Cancer research 2009;69(24):9448-56.
2009: Lucy J Schmidt; Kevin M Regan; S Keith Anderson; Zhifu Sun; Karla V Ballman; Donald J Tindall
Effects of the 5 alpha-reductase inhibitor dutasteride on gene expression in prostate cancer xenografts.
The Prostate 2009;69(16):1730-43.
2009: Hannelore V Heemers; Kevin M Regan; Lucy J Schmidt; S Keith Anderson; Karla V Ballman; Donald J Tindall
Androgen modulation of coregulator expression in prostate cancer cells.
Molecular endocrinology (Baltimore, Md.) 2009;23(4):572-83.
2009: Stephen A Boorjian; Hannelore V Heemers; Igor Frank; Sara A Farmer; Lucy J Schmidt; Thomas J Sebo; Donald J Tindall
Expression and significance of androgen receptor coactivators in urothelial carcinoma of the bladder.
Endocrine-related cancer 2009;16(1):123-37.
2008: Scott M Dehm; Lucy J Schmidt; Hannelore V Heemers; Robert L Vessella; Donald J Tindall
Splicing of a novel androgen receptor exon generates a constitutively active androgen receptor that mediates prostate cancer therapy resistance.
Cancer research 2008;68(13):5469-77.
2007: Scott M Dehm; Kevin M Regan; Lucy J Schmidt; Donald J Tindall
Selective role of an NH2-terminal WxxLF motif for aberrant androgen receptor activation in androgen depletion independent prostate cancer cells.
Cancer research 2007;67(20):10067-77.
2007: Lucy J Schmidt; Karla V Ballman; Donald J Tindall
Inhibition of fatty acid synthase activity in prostate cancer cells by dutasteride.
The Prostate 2007;67(10):1111-20.
2006: Horacio Murillo; Lucy J Schmidt; Melissa Karter; Kari A Hafner; Yasushi Kondo; Karla V Ballman; George Vasmatzis; Robert B Jenkins; Donald J Tindall
Prostate cancer cells use genetic and epigenetic mechanisms for progression to androgen independence.
Genes, chromosomes & cancer 2006;45(7):702-16.
2005: Jose D Debes; Barbara Comuzzi; Lucy J Schmidt; Scott M Dehm; Zoran Culig; Donald J Tindall
p300 regulates androgen receptor-independent expression of prostate-specific antigen in prostate cancer cells treated chronically with interleukin-6.
Cancer research 2005;65(13):5965-73.
2004: Lucy J Schmidt; Horacio Murillo; Donald J Tindall
Gene expression in prostate cancer cells treated with the dual 5 alpha-reductase inhibitor dutasteride.
Journal of andrology 2004;25(6):944-53.
2002: Jose D Debes; Lucy J Schmidt; Haojie Huang; Donald J Tindall
p300 mediates androgen-independent transactivation of the androgen receptor by interleukin 6.
Cancer research 2002;62(20):5632-6.
2002: Ofelia L Zegarra-Moro; Lucy J Schmidt; Haojie Huang; Donald J Tindall
Disruption of androgen receptor function inhibits proliferation of androgen-refractory prostate cancer cells.
Cancer research 2002;62(4):1008-13.
2001: Horacio Murillo; Haojie Huang; Lucy J Schmidt; David I Smith; Donald J Tindall
Role of PI3K signaling in survival and progression of LNCaP prostate cancer cells to the androgen refractory state.
Endocrinology 2001;142(11):4795-805.
2001: Haojie Huang; J C Cheville; Y Pan; P C Roche; Lucy J Schmidt; Donald J Tindall
PTEN induces chemosensitivity in PTEN-mutated prostate cancer cells by suppression of Bcl-2 expression.
The Journal of biological chemistry 2001;276(42):38830-6.
2001: Horacio Murillo; Lucy J Schmidt; Donald J Tindall
Tyrphostin AG825 triggers p38 mitogen-activated protein kinase-dependent apoptosis in androgen-independent prostate cancer cells C4 and C4-2.
Cancer research 2001;61(20):7408-12.
1998: M V Kumar; E A Jones; S J Felts; M D Blexrud; M E Grossmann; L J Blok; Lucy J Schmidt; Donald J Tindall
Characterization of a TPA-response element in the 5'-flanking region of the androgen receptor gene.
Journal of andrology 1998;19(5):595-602.